XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.2
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jul. 26, 2022
Jul. 22, 2022
May 03, 2022
Feb. 15, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]                  
Common stock voting rights             The holders of the Company’s common stock are entitled to one vote per share.    
Common stock, shares authorized         100,000,000   100,000,000   100,000,000
Preferred stock, shares authorized         20,000,000   20,000,000   20,000,000
Incentive plan description     (i) increase the aggregate number of shares available for the grant of awards by 146,083 shares to a total of 200,000 shares, and (ii) add an “evergreen” provision whereby the number of shares authorized for issuance pursuant to awards under the Incentive Plan will be automatically increased on the first trading date immediately following the date the Company issues any share of Common Stock (defined below) to any person or entity, to the extent necessary so that the number of shares of the Company’s Common Stock authorized for issuance under the Incentive Plan will equal the greater of (x) 200,000 shares, and (y) 15% of the total number of shares of the Company’s Common Stock outstanding as of such issuance date. The Plan Amendment was approved by the Company’s shareholders at a special meeting of the Company’s shareholders held on July 14, 2022.            
Stock based compensation, expenses         $ 825,363 $ 622,596 $ 1,310,112 $ 1,342,363  
Share-Based Payment Arrangement, Option [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock based compensation, expenses         54,375 48,697 102,461 85,686  
Stock-based compensation, unamortized         138,388   $ 138,388    
Weighted average period             1 year 6 months    
Restricted Stock [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock based compensation, expenses         0 6,250 $ 0 18,113  
Common stock vested restricted stock units             708    
Restricted Stock Units (RSUs) [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock based compensation, expenses         825,363 $ 622,596 $ 1,310,112 $ 1,342,363  
Stock-based compensation, unamortized         $ 2,157,127   $ 2,157,127    
Weighted average period             2 years 6 months    
Common stock vested restricted stock units             57,280    
Common Stock [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock Issued During Period, Shares, Conversion of Units         63,511   63,511 2,122  
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Common stock vested restricted stock units             55,622    
Common stock vested restricted stock units             38,382    
RD Offering and Pipe Investment Options [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Proceeds from RD offerings $ 8,000,000                
Offerings costs 7,100,000                
Payments of allocated equity 3,200,000                
Payments of investment option liability 4,300,000                
Payments of stock issuance costs recorded expense $ 400,000                
Registered Direct Securities Purchase Agreement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock Issued During Period, Shares, New Issues   375,000              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   258,500              
Proceeds from issuance of warrants   $ 3,000,000              
Sale of Stock, Number of Shares Issued in Transaction   116,500              
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.0001              
PIPE Securities Purchase Agreement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock Issued During Period, Shares, New Issues   625,000              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   509,000              
Proceeds from issuance of warrants   $ 5,000,000              
Sale of Stock, Number of Shares Issued in Transaction   116,000              
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.0001              
Underwriters [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock Issued During Period, Shares, New Issues       60,000          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       60,000          
Stock issued during period shares warrant exercised.       60,000          
Proceeds from Issuance Initial Public Offering       $ 9,100,000          
Deferred Offering Costs       5,800,000          
[custom:WarrantLiability-0]       3,600,000          
Proceeds from issuance of warrants       $ 300,000          
IPO [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Stock Issued During Period, Shares, New Issues       400,000          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       400,000          
Proceeds from common stock       $ 10,000,000